{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Pacheco-Jaime L"],"funding":["Ministry of Science and Innovation","AEI","MCIU","La Marató de TV3 Foundation","Unión Europea NextGenerationEU","Agency for Management of University and Research Grants","University of Barcelona","La Caixa Fundation","Generalitat de Catalunya","Plan de Recuperación, Transformación y Resiliencia","Spanish Ministry of Science, Innovation and Universities","María de Maeztu Unit of Excellence","Spanish Ministry of Economy and Competitiveness","Institute of Neurosciences"],"pagination":["fcaf070"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11851114"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["7(1)"],"pubmed_abstract":["It has been estimated that ∼4% of individuals infected with SARS-CoV-2 will be diagnosed with post-COVID condition. Previous studies have evidenced the presence of cognitive dysfunction and structural brain changes in infected individuals; however, the relationship between structural changes and cognitive alterations in post-COVID condition is still not clear. Consequently, the aim of this work is to study structural brain alterations in post-COVID condition patients after almost 2 years of infection and their likely relationship with patients' cognitive impairment. Additionally, the association with blood biomarkers and clinical variables was also explored. One hundred and twenty-eight individuals with post-COVID condition and 37 non-infected healthy controls from the Nautilus Project (Cl"],"journal":["Brain communications"],"pubmed_title":["Structural brain changes in post-COVID condition and its relationship with cognitive impairment."],"pmcid":["PMC11851114"],"funding_grant_id":["SGR 2021SGR00801","LCF/BQ/DR22/11950012","TED2021-130409B-C51","TED2021-130409A-C52","202111-30-31-32","202PANDE00053","PRE2018-086675","PRE2021-099674","CEX2021-001159-M"],"pubmed_authors":["Prats-Paris A","Alsina S","Forne S","Munoz-Moreno JA","Rico I","Arauzo V","Canizares S","Martin-Barcelo C","Pardo J","Roura I","Bargallo N","Capdevila-Lacasa C","Carreras-Vidal L","Segura B","Ariza M","Campabadal A","Garzon T","Sabe N","Bejar J","Molina Y","Cullell M","Sala-Llonch R","Almeria M","NAUTILUS-Project Collaborative Group","Bartes-Plans A","Caballero J","Tayo-Juli C","Ferre A","Garcia-Vicente C","Gonzalez-Aguado E","Reverte-Vilarroya S","Junque C","Casas L","Vega S","Barrue C","Cortes CU","Lozano M","Oltra J","Vazquez-Rivera S","Ciudad MJ","Maldonado-Belmonte MJ","Forcadell-Ferreres E","Pacheco-Jaime L","Valles-Pauls B","Balague-Marmana M","Olive V","Navarro S","Bernia JA","Hernandez AG","Bailles E","Cano N","Garolera M","Munoz-Padros J"],"additional_accession":[]},"is_claimable":false,"name":"Structural brain changes in post-COVID condition and its relationship with cognitive impairment.","description":"It has been estimated that ∼4% of individuals infected with SARS-CoV-2 will be diagnosed with post-COVID condition. Previous studies have evidenced the presence of cognitive dysfunction and structural brain changes in infected individuals; however, the relationship between structural changes and cognitive alterations in post-COVID condition is still not clear. Consequently, the aim of this work is to study structural brain alterations in post-COVID condition patients after almost 2 years of infection and their likely relationship with patients' cognitive impairment. Additionally, the association with blood biomarkers and clinical variables was also explored. One hundred and twenty-eight individuals with post-COVID condition and 37 non-infected healthy controls from the Nautilus Project (Cl","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025","modification":"2026-06-03T04:41:01.76Z","creation":"2025-04-04T00:21:45.498Z"},"accession":"S-EPMC11851114","cross_references":{"pubmed":["40008326"],"doi":["10.1093/braincomms/fcaf070"]}}